Aberrant methylation as a main mechanism of TSGs silencing in PTC

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 1, 2011, Pages 137-157

  Czarnecka, Karolina ^a   Pastuszak Lewandoska, Dorota ^a   Migdalska Sek, Monika ^a   Nawrot, Ewa ^a   Brzezinski, Jan ^a   Dedecjus, Marek ^a   Pomorski, Lech ^a   Brzezianska, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Bisulfite specific PCR; Fractional allele loss; Gene expression; Imprinted region; Loss of heterozygosity; Methylation index; Methylation pattern; Methylation specific PCR; Microsatellite instability; Nodular goitre; Non imprinted region; Papillary thyroid carcinoma; Realtime PCR; Tumour suppressor gene

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; GENOMIC DNA; POTASSIUM CHANNEL KCNQ1; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TUMOR SUPPRESSOR PROTEIN; UVOMORULIN; VON HIPPEL LINDAU PROTEIN; BISULFITE; MICROSATELLITE DNA; PRIMER DNA; SULFITE;

ADULT; AGED; ARTICLE; CANCER TISSUE; CARCINOGENESIS; CHROMOSOME NOR; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE SILENCING; GENOMIC INSTABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; MICROSATELLITE INSTABILITY; NODULAR GOITER; NUCLEOTIDE SEQUENCE; THYROID CARCINOMA; TUMOR SUPPRESSOR GENE; COMPARATIVE STUDY; DNA SEQUENCE; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; POLAND; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; THYROID TUMOR;

ADULT; BASE SEQUENCE; DNA METHYLATION; DNA PRIMERS; FEMALE; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SPECTROPHOTOMETRY; STATISTICS, NONPARAMETRIC; SULFITES; THYROID NEOPLASMS;

EID: 79957922852     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Sherma, S.I.: Thyroid carcinoma. Lancet 361, 501-511 (2003)
2. Kimura, E.T., M.N. Nikiforova, Z. Zhu, J.A. Knauf, Y.E. Nikiforov & J.A. Fagin: High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63, 1454-1457 (2003) (Pubitemid 36373628)
3. Soares, P., V. Trovisco, A.S. Rocha, J. Lima, P. Castro, A. Preto, V. Maximo, T. Botelho, R. Seruca & M. Sobrinho-Simoes: BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22, 4578-4580 (2003) (Pubitemid 36920701)
4. Mitsutake, N., M. Miyagishi, S. Mitsutake, N. Akeno, C. Mesa, Jr., J.A. Knauf, L. Zhang, K. Taira & J.A. Fagin: BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis. Endocrinology 147, 1014- 1019 (2006) (Pubitemid 43113021)
5. Xing, M.: BRAF mutation in thyroid cancer. Endocr Relat Cancer 12, 245-262 (2005) (Pubitemid 40896444)
6. Brzezianska, E., M. Karbownik, M. Migdalska-Sek, D. Pastuszak-Lewandoska, J. Wloch & A. Lewinski: Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population. Mutat Res 599, 26-35 (2006) (Pubitemid 44041501)
7. Brzezianska, E., D. Pastuszak-Lewandoska, K. Wojciechowska, M. Migdalska-Sek, A. Cyniak-Magierska, E. Nawrot & A. Lewinski: Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population. Neuro Endocrinol Lett 28, 351-359 (2007) (Pubitemid 47577711)
8. Carta, C., S. Moretti, L. Passeri, F. Barbi, N. Avenia, A. Cavaliere, M. Monacelli, A. Macchiarulo, F. Santeusanio, M. Tartaglia & E. Puxeddu: Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Clin Endocrinol (Oxf) 64, 105-109 (2006)
9. Frattini, M., C. Ferrario, P. Bressan, D. Balestra, L. De Cecco, P. Mondellini, I. Bongarzone, P. Collini, M. Gariboldi, S. Pilotti, M.A. Pierotti & A. Greco: Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer. Oncogene 23, 7436-7440 (2004) (Pubitemid 39382146)
10. Nikiforov, Y.E.: RET/PTC rearrangement in thyroid tumors. Endocr Pathol 13, 3-16 (2002) (Pubitemid 34665111)
11. Kjellman, P., D.L. Learoyd, M. Messina, G. Weber, A. Hoog, G. Wallin, C. Larsson, B. G. Robinson & J. Zedenius: Expression of the RET proto-oncogene in papillary thyroid carcinoma and its correlation with clinical outcome. Br J Surg 88, 557-563 (2001) (Pubitemid 32291238)
12. Melillo, R.M., M.D. Castellone, V. Guarino, V. De Falco, A.M. Cirafici, G. Salvatore, F. Caiazzo, F. Basolo, R. Giannini, M. Kruhoffer, T. Orntoft, A. Fusco & M. Santoro: The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest 115, 1068-1081 (2005) (Pubitemid 40489412)
13. Baylin, S.B. & J.E. Ohm: Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6, 107-116 (2006) (Pubitemid 43361543)
14. Ting, A.H., K.M. McGarvey & S.B. Baylin: The cancer epigenome-components and functional correlates. Genes Dev 20, 3215-3231 (2006)
15. Robertson, K.D.: DNA methylation and human disease. Nat Rev Genet 6, 597-610 (2001) (Pubitemid 41044297)
16. Bird, A.: DNA methylation patterns and epigenetic memory. Genes Dev 16, 6-21 (2002) (Pubitemid 34049633)
17. Herman, J.G. & S.B. Baylin: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349, 2042-2054 (2003) (Pubitemid 37448928)
18. Schagdarsurengin, U., O. Gimm, C. Hoang-Vu, H. Dralle, G.P. Pfeifer & R. Dammann: Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Cancer Res 62, 3698-3701 (2002) (Pubitemid 34728849)
19. Xing, M., Y. Cohen, E. Mambo, G. Tallini, R. Udelsman, P.W. Ladenson & D. Sidransky: Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis. Cancer Res 64, 1664-1668 (2004) (Pubitemid 38428687)
20. Hoque, M.O., E. Rosenbaum, W.H. Westra, M. Xing, P. Ladenson, M.A. Zeiger, D. Sidransky & C.B. Umbricht: Quantitative assessment of promoter methylation profiles in thyroid neoplasms. J Clin Endocrinol Metab 90, 4011-4018 (2005) (Pubitemid 41058165)
21. Alvarez-Nunez, F., E. Bussaglia, D. Mauricio, J. Ybarra, M. Vilar, E. Lerma, A. de Leiva & X. Matias-Guiu: PTEN promoter methylation in sporadic thyroid carcinomas. Thyroid 16, 17- 23 (2006) (Pubitemid 43346499)
22. Hu, S., D. Liu, R.P. Tufano, K.A. Carson, E. Rosenbaum, Y. Cohen, E.H. Holt, K. Kiseljak-Vassiliades, K.J. Rhoden, S. Tolaney, S. Condouris, G. Tallini, W.H. Westra, C.B. Umbricht, M.A. Zeiger, J.A. Califano, V. Vasko & M. Xing: Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer. Int J Cancer 119, 2322-2329 (2006) (Pubitemid 44546951)
23. Xing, M.: Gene methylation in thyroid tumorigenesis. Endocrinology 148, 948-953 (2007)
24. Xing, M., Y. Tokumaru, G. Wu, W.B. Westra, P.W. Ladenson & D. Sidransky: Hypermethylation of the Pendred syndrome gene SLC26A4 is an early event in thyroid tumorigenesis. Cancer Res 63, 2312-2315 (2003) (Pubitemid 36538642)
25. Kitamura, Y., K. Shimizu, S. Tanaka, K. Ito & M. Emi: Association of allelic loss on 1q, 4p, 7q, 9p, 9q, and 16q with postoperative death in papillary thyroid carcinoma. Clin Cancer Res 6, 1819-1825 (2000) (Pubitemid 30305077)
26. Bauer, A.J., L.R. Cavalli, J.D. Rone, G.L. Francis, H.B. Burch, R.M. Tuttle, M.D. Ringel, C.A. Stratakis & B.R. Haddad: Evaluation of adult papillary thyroid carcinomas by comparative genomic hybridization and microsatellite instability analysis. Cancer Genet Cytogenet 135, 182- 186 (2002) (Pubitemid 34786771)
27. Vaish, M., A. Mishra, M. Kaushal, S.K. Mishra & B. Mittal: Microsatellite instability and its correlation with clinicopathological features in a series of thyroid tumors prevalent in iodine deficient areas. Exp Mol Med 36, 122-129 (2004) (Pubitemid 38667920)
28. Rodrigues-Serpa, A., A. Catarino & J. Soares: Loss of heterozygosity in follicular and papillary thyroid carcinomas. Cancer Genet Cytogenet 141, 26-31 (2003) (Pubitemid 36165193)
29. Lin, X., S.D. Finkelstein, B. Zhu & J. F. Silverman: Molecular analysis of multifocal papillary thyroid carcinoma. J Mol Endocrinol 41, 195-203 (2008)
30. Wozniak, A., M. Wiench, A. Olejniczak, J. Wloch, A. Lachinski, D. Lange, T. Olczyk, B. Jarzab & J. Limon: Loss of heterozygosity in 73 human thyroid tumors. Neuro Endocrinol Lett 26, 521-525 (2005) (Pubitemid 43013725)
31. Sarquis, M.S., F. Weber, L. Shen, C.E. Broelsch, S.M. Jhiang, J. Zedenius, A. Frilling & C. Eng: High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas. J Clin Endocrinol Metab 91, 262-269 (2006) (Pubitemid 43069147)
32. Feltus, F.A., E.K. Lee, J.F. Costello, C. Plass & P.M. Vertino: Predicting aberrant CpG island methylation. Proc Natl Acad Sci U S A 100, 12253-12258 (2003) (Pubitemid 37271547)
33. Herman, J.G., J.R. Graff, S. Myohanen, B.D. Nelkin & S.B. Baylin: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93, 9821-9826 (1996) (Pubitemid 26296693)
34. Grunau, C., E. Renault, A. Rosenthal & G. Roizes: MethDB - a public database for DNA methylation data. Nucleic Acids Res 29, 270-274 (2001) (Pubitemid 32054465)
35. Farrand, K., B. Delahunt, X.L. Wang, B. McIver, I.D. Hay, J.R. Goellner, N.L. Eberhardt & S.K. Grebe: High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene. J Clin Endocrinol Metab 87, 4715-4721 (2002) (Pubitemid 35247066)
36. Trovato, M., A. Ulivieri, R. Dominici, R.M. Ruggeri, E. Vitarelli, S. Benvenga, G. Barresi, F. Trimarchi, E. Brunetti, A. Vecchione, M. Andreoli & S. Sciacchitano: Clinicopathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions. Endocr Relat Cancer 11, 365-376 (2004) (Pubitemid 38832837)
37. Greene, L.F., D.L. Page, A.M. Fritz, C.M. Balch, D.G. Haller, M. Morrow. AJCC, Thyroid. In: AJCC Cancer Staging Manual, 6th. edition, Eds: F.L. Greene, D.L. Page, I.D. Fleming, A.F. Fritz, C.M. Balch, D.G. Haller, M. Morrow. Springer-Verlag, New York, NY, 77-87 (2002)
38. Lewinski, A. & K. Wojciechowska: Genetic background of carcinogenesis in the thyroid gland. Neuro Endocrinol Lett 28, 77-105 (2007) (Pubitemid 46744779)
39. Feng, Q., S.E. Hawes, J.E. Stern, L. Wiens, H. Lu, Z.M. Dong, C.D. Jordan, N.B. Kiviat & H. Vesselle: DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 17, 645-654 (2008) (Pubitemid 351469215)
40. Negraes, P.D., F.P. Favaro, J.L. Camargo, M.L. Oliveira, J. Goldberg, C.A. Rainho & D.M. Salvadori: DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection. BMC Cancer 8, 238 (2008)
41. Weber, F., M.A. Aldred, C.D. Morrison, C. Plass, A. Frilling, C.E. Broelsch, K.A. Waite & C. Eng: Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis. J Clin Endocrinol Metab 90, 1149-1155 (2005) (Pubitemid 40279247)
42. Ishida, E., M. Nakamura, K. Shimada, T. Higuchi, K. Takatsu, K. Yane & N. Konishi: DNA hypermethylation status of multiple genes in papillary thyroid carcinomas. Pathobiology 74, 344-352 (2007) (Pubitemid 350273706)
43. Schagdarsurengin, U., O. Gimm, H. Dralle, C. Hoang- Vu & R. Dammann: CpG island methylation of tumorrelated promoters occurs preferentially in undifferentiated carcinoma. Thyroid 16, 633-642 (2006)
44. Graff, J.R., V.E. Greenberg, J.G. Herman, W.H. Westra, E.R. Boghaert, K.B. Ain, M. Saji, M.A. Zeiger, S.G. Zimmer & S.B. Baylin: Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Cancer Res 58, 2063-2066 (1998) (Pubitemid 28232884)
45. Rocha, A.S., P. Soares, R. Seruca, V. Maximo, X. Matias-Guiu, J. Cameselle-Teijeiro & M. Sobrinho-Simoes: Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J Pathol 194, 358-366 (2001) (Pubitemid 32624563)
46. Fujii, S., R.Z. Luo, J. Yuan, M. Kadota, M. Oshimura, S.R. Dent, Y. Kondo, J.P. Issa, R.C. Bast, Jr. & Y. Yu: Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation. Hum Mol Genet 12, 1791-1800 (2003) (Pubitemid 36944134)
47. Wreesmann, V.B., R.A. Ghossein, M. Hezel, D. Banerjee, A.R. Shaha, R.M. Tuttle, J.P. Shah, P.H. Rao & B. Singh: Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer 40, 355-364 (2004) (Pubitemid 38902548)
48. Nakamura, N., J.A. Carney, L. Jin, S. Kajita, J. Pallares, H. Zhang, X. Qian, T.J. Sebo, L.A. Erickson & R.V. Lloyd: RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors. Lab Invest 85, 1065-1075 (2005) (Pubitemid 43073981)
49. Wong, I.H., J. Chan, J. Wong & P.K. Tam: Ubiquitous aberrant RASSF1A promoter methylation in childhood neoplasia. Clin Cancer Res 10, 994-1002 (2004) (Pubitemid 38198901)
50. Porra, V., C. Ferraro-Peyret, C. Durand, S. Selmi-Ruby, H. Giroud, N. Berger-Dutrieux, M. Decaussin, J.L. Peix, C. Bournaud, J. Orgiazzi, F. Borson-Chazot, R. Dante & B. Rousset: Silencing of the tumor suppressor gene SLC5A8 is associated with BRAF mutations in classical papillary thyroid carcinomas. J Clin Endocrinol Metab 90, 3028- 3035 (2005) (Pubitemid 40686360)
51. Hinze, R., C. Boltze, A. Meye, H.J. Holzhausen, H. Dralle & F.W. Rath: Expression of the von Hippel-Lindau tumor suppressor gene in nonneoplastic and neoplastic lesions of the thyroid. Endocr Pathol 11, 145-155 (2000) (Pubitemid 30610124)
52. Xu, X.L., J. Yu, H.Y. Zhang, M.H. Sun, J. Gu, X. Du, D.R. Shi, P. Wang, Z.H. Yang & J.D. Zhu: Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol 10, 3441-3454 (2004) (Pubitemid 39549544)
53. Vaissiere, T., R.J. Hung, D. Zaridze, A. Moukeria, C. Cuenin, V. Fasolo, G. Ferro, A. Paliwal, P. Hainaut, P. Brennan, J. Tost, P. Boffetta & Z. Herceg: Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 69, 243-252 (2009)
54. Esteller, M., P.G. Corn, S.B. Baylin & J.G. Herman: A gene hypermethylation profile of human cancer. Cancer Res 61, 3225-3229 (2001) (Pubitemid 32695003)
55. Elisei, R., M. Shiohara, H.P. Koeffler & J.A. Fagin: Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Cancer 83, 2185-2193 (1998) (Pubitemid 28525401)
56. Feinberg, A.P.: Genomic imprinting and cancer. In: The Genetic Basis of Human Cancer. Eds: B. Vogelstein, K.W. Kinzler. McGraw Hill Medical Publishing, NY (1998), 95- 107
57. Kjellman, P., S. Lagercrantz, A. Hoog, G. Wallin, C. Larsson & J. Zedenius: Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma. Genes Chromosomes Cancer 32, 43-49 (2001) (Pubitemid 32737783)
58. Martinez, R., J.I. Martin-Subero, V. Rohde, M. Kirsch, M. Alaminos, A.F. Fernandez, S. Ropero, G. Schackert & M. Esteller: A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics 4, 255-264 (2009)
59. Li, Y., G. Meng & Q.N. Guo: Changes in genomic imprinting and gene expression associated with transformation in a model of human osteosarcoma. Exp Mol Pathol 84, 234-239 (2008)
60. Pedersen, I.S., P.A. Dervan, D. Broderick, M. Harrison, N. Miller, E. Delany, D. O'Shea, P. Costello, A. McGoldrick, G. Keating, B. Tobin, T. Gorey & A. McCann: Frequent loss of imprinting of PEG1/MEST in invasive breast cancer. Cancer Res 59, 5449-5451 (1999) (Pubitemid 29526454)
61. Trovato, M., F. Fraggetta, D. Villari, D. Batolo, K. Mackey, F. Trimarchi & S. Benvenga: Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer. J Clin Endocrinol Metab 84, 3235-3240 (1999) (Pubitemid 30646950)
62. Califano, J.A., M.M. Johns, 3rd, W.H. Westra, M.N. Lango, D. Eisele, M. Saji, M.A. Zeiger, R. Udelsman, W.M. Koch & D. Sidransky: An allelotype of papillary thyroid cancer. Int J Cancer 69, 442-444 (1996) (Pubitemid 27050518)
63. Kleer, C.G., B.R. Bryant, T.J. Giordano, M. Sobel & M.J. Merino: Genetic Changes in Chromosomes 1p and 17p in Thyroid Cancer Progression. Endocr Pathol 11, 137- 143 (2000) (Pubitemid 30610123)